If the idea of a health and wellness hotel brand seems odd, think again.
Happy Friday! Take a look at some of this morning's early movers:
Chief executives at some of the biggest U.S. biotech and pharmaceutical companies are at the annual JPMorgan health care conference in San Francisco. Here's what some of them told CNBC on Tuesday.
Discussing how Obamacare's new 2.3% tax on the biggest medical device makers is impacting business, with Omar Ishrak, Medtronic CEO; Michael Mussallem, Edwards Lifesciences CEO; and Stephen MacMillan, Stryker Corporation CEO.
CNBC contributor Michael Farr offers his ten stock picks for 2012.
Despite calls from some of its investors, Medtronic won't be spinning off any more business units, Chief Executive Omar Ishrak told CNBC Tuesday.
Medtronic's profits rose in the second quarter, beating Wall Street estimates. Omar Ishrak, CEO of Medtronic, weighs in.
The mystery isn’t why Hewlett-Packard is likely to part ways with its chief executive, Léo Apotheker, after just a year in the job. It’s why he was hired in the first place. The New York Times reports.
Stocks closed near session highs Tuesday, with the Dow posting its biggest gain in almost two weeks, despite a 5.8-magnitude earthquake in Virginia that shook parts of the U.S. East Coast and after investors shrugged off a handful of disappointing economic news.
Futures were higher Tuesday, boosted by better-than-expected manufacturing data in Germany and China, and ahead of a handful of reprots in the U.S.
Stocks ended modestly lower amid further signs of economic weakness, and despite a positive call on commodities by Goldman Sachs, which lifted prices of oil and metals.
Stocks turned modestly lower before the close amid more news of weakness in the nation's manufacturing sector, and a positive call on commodities by Goldman Sachs lifted prices of oil and metals.
Stocks turned mixed a day after a steep selloff, although energy and materials sectors were lifted by a positive report on commodities prices by Goldman Sachs.
Stock index futures gained ahead of the open Tuesday, tracking European and Asian shares higher a day after the markets sold off amid fears over euro zone debt troubles and falling commodity prices.
"There's no place to put any money," one trader lamented to me this morning, arguing why he thought the market had a good chance of rising even through the QE2 uncertainty.
Medtronic, the world's largest medical device maker, says its fourth-quarter net income dropped 19 percent on expenses related to its recent layoffs.
The "Mad Money" host reveals what he plans to watch in the days to come.
Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector: large-cap pharmaceutical stocks.
Cramer makes the call on viewers' favorite stocks.